These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37256175)

  • 1. LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer.
    Yang M; Liu X; Tang X; Sun W; Ji Z
    Front Oncol; 2023; 13():1160965. PubMed ID: 37256175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
    BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
    Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
    Kodama H; Yoneyama T; Tanaka T; Noro D; Tobisawa Y; Yamamoto H; Suto S; Hatakeyama S; Mori K; Yoneyama T; Hashimoto Y; Kakizaki I; Nakaji S; Ohyama C
    Cancer Med; 2021 Feb; 10(4):1297-1313. PubMed ID: 33455069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer.
    Cheng X; Liu X; Liu X; Guo Z; Sun H; Zhang M; Ji Z; Sun W
    Front Oncol; 2018; 8():494. PubMed ID: 30450336
    [No Abstract]   [Full Text] [Related]  

  • 6. LC-MS-based urine metabolomics analysis of chronic subdural hematoma for biomarker discovery.
    Sun J; Ou Y; Liu X; Sun H; Guo Z; Qi F; Lan Y; Liu W; Sun W
    Proteomics Clin Appl; 2024 Jan; 18(1):e2200107. PubMed ID: 37697649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
    Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
    Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
    Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
    Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC.
    Liu X; Zhang M; Liu X; Sun H; Guo Z; Tang X; Wang Z; Li J; Li H; Sun W; Zhang Y
    Front Oncol; 2019; 9():663. PubMed ID: 31380290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
    Jacyna J; Wawrzyniak R; Balayssac S; Gilard V; Malet-Martino M; Sawicka A; Kordalewska M; Nowicki Ł; Kurek E; Bulska E; Patejko M; Markuszewski M; Gutknecht P; Matuszewski M; Siebert J; Kaliszan R; Markuszewski MJ
    Talanta; 2019 Sep; 202():572-579. PubMed ID: 31171223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing urinary metabolomic signatures as early bladder cancer diagnostic markers.
    Shen C; Sun Z; Chen D; Su X; Jiang J; Li G; Lin B; Yan J
    OMICS; 2015 Jan; 19(1):1-11. PubMed ID: 25562196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Cana F; Herranz R; Pérez-Ardavín J; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    World J Urol; 2022 Oct; 40(10):2387-2398. PubMed ID: 36057894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urine and serum metabolomics study of gastroesophageal reflux disease in TCM syndrome differentiation using UPLC-Q-TOF/MS.
    Ye X; Wang X; Wang Y; Sun W; Chen Y; Wang D; Li Z; Li Z
    J Pharm Biomed Anal; 2021 Nov; 206():114369. PubMed ID: 34551376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma.
    Liao Z; Zhao L; Zhong F; Zhou Y; Lu T; Liu L; Gong X; Li J; Rao J
    Rapid Commun Mass Spectrom; 2023 Mar; 37(6):e9469. PubMed ID: 36593223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma.
    Urabe F; Matsuzaki J; Takeshita F; Kishida T; Ochiya T; Hirai K
    Cancer Sci; 2022 Oct; 113(10):3510-3517. PubMed ID: 35848873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
    Boonchaisri S; Rochfort S; Stevenson T; Dias DA
    Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS.
    Chen J; Hou H; Chen H; Luo Y; Zhang L; Zhang Y; Liu H; Zhang F; Liu Y; Wang A; Hu Q
    J Pharm Biomed Anal; 2019 Apr; 167():83-89. PubMed ID: 30759408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urine metabolomics analysis based on ultra performance liquid chromatography-high resolution mass spectrometry combined with osmolality calibration sample concentration variability].
    He Z; Lin H; Gui J; Zhu W; He J; Wang H; Feng L
    Se Pu; 2021 Apr; 39(4):391-398. PubMed ID: 34227759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs.
    Tsamouri MM; Durbin-Johnson BP; Culp WTN; Palm CA; Parikh M; Kent MS; Ghosh PM
    Metabolites; 2022 Feb; 12(3):. PubMed ID: 35323643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect.
    Friedman P; Yilmaz A; Ugur Z; Jafar F; Whitten A; Ustun I; Turkoglu O; Graham S; Bahado Singh R
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6380-6387. PubMed ID: 33944672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.